Top compounds associated with response to LRRC24


Feature Type Standardized
Nominal ANOVA
mRNA thapsigargin gCSI pan-cancer AAC -0.16 0.004
mRNA thapsigargin GDSC1000 pan-cancer AAC -0.072 0.05
mRNA tigecycline CTRPv2 pan-cancer AAC 0.028 0.6
mRNA tipifarnib CTRPv2 pan-cancer AAC 0.14 5e-06
mRNA tivantinib CTRPv2 pan-cancer AAC 0.08 0.08
mRNA tivozanib CTRPv2 pan-cancer AAC 0.068 0.06
mRNA tivozanib GDSC1000 pan-cancer AAC 0.055 0.1
mRNA tosedostat CTRPv2 pan-cancer AAC 0.056 0.1
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.091 0.009
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.07 0.05
Download CSV